BioMarin Pharmaceutical Inc - Company Profile

Powered by

All the sales intelligence you need on BioMarin Pharmaceutical Inc in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how BioMarin Pharmaceutical Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with BioMarin Pharmaceutical Inc.

Back to companies

BioMarin Pharmaceutical Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

The following section provides information on BioMarin Pharmaceutical Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into BioMarin Pharmaceutical Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Ian T. Clark

Chairman Executive Board Since: 2026

Mr. Ian T. Clark has been the Chairman of the company since June 2026 and Director of the company since 2025.

Read Hide full bio of Ian T. Clark

Alexander Hardy

Director; President; Chief Executive Officer Executive Board Since: 2023 Age: 57

Mr. Alexander Hardy has been the President, Chief Executive Officer, and Director of the company since 2023. Prior to this, he served as the Chief Executive Officer of Genentech Inc, Head of Global Product Strategy at Roche, and as Head of Asia Pacific at Roche Pharma. Mr. Hardy also served in various leadership roles at Genentech Incand Novartis. Currently, he also serves as a Director with Pharmaceutical Research and Manufacturers of America (PhRMA) and has more than 30 years in the global pharmaceutical industry.

Read Hide full bio of Alexander Hardy

Brian R. Mueller

Chief Financial Officer; Executive Vice President Senior Management Since: 2020 Age: 52

Mr. Brian R. Mueller has been the Executive Vice President and Chief Financial Officer of the company since 2020. Prior to this, he served as the Chief Accounting Officer and Corporate Controller of the company. Mr. Mueller also served as the Senior Manager for KPMG and with Arthur Andersen LLP.

Read Hide full bio of Brian R. Mueller

C. Greg Guyer, PhD

Chief Technology Officer; Executive Vice President Senior Management Since: 2020 Age: 64

Mr. C. Greg Guyer has been the Chief Technical Officer and Executive Vice President of the company since 2020. Prior to this, has served as the Global Head of Operations at Bristol Myers Squibb and Merck & Co Inc. Previously, he served as the Senior Vice President Operations, Biologics, Therapeutic Proteins and Sterile Products at Merck. Mr. Guyer also served as the Director, Office of Generic Drugs at FDA.

Read Hide full bio of C. Greg Guyer, PhD

G. Eric Davis

Executive Vice President; Secretary; Chief Legal Officer Senior Management Since: 2022 Age: 55

Mr. Eric Davis has been the Executive Vice President, Secretary, and Chief Legal Officer of the company since 2022. Prior to this, he served as the Executive Vice President, General Counsel and Secretary; Senior Vice President, General Counsel and Secretary; and as Vice President, General Counsel and Secretary of the company. Mr. Davis has also served with Paul Hastings LLP.

Read Hide full bio of G. Eric Davis
Gain a 360-degree view of BioMarin Pharmaceutical Inc and make more informed decisions for your business Gain a 360-degree view of BioMarin Pharmaceutical Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer